Theranica

Theranica

Signal active

Organization

Contact Information

Overview

Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, and affordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.

About

Industries

Biotechnology, Medical, Therapeutics

Founded

2016

Employees

11-50

Headquarters locations

Netanya, HaMerkaz, Israel, Asia

Social

Profile Resume

Theranica headquartered in Asia, operates in the Biotechnology, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $4.1B in funding across 48 round(s). With a team of 11-50 employees, Theranica is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Theranica, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Ronen Jashek

Ronen Jashek

VP Marketing & Business Development, Co-Founder

imagePlace Rostislav Barabash

Rostislav Barabash

VP Research & Development, Co-Founder

Funding Rounds

Funding rounds

4

Investors

1

Lead Investors

0

Total Funding Amount

$86.0M

Details

4

Theranica has raised a total of $86.0M in funding over 4 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2019Early Stage Venture35.0M
2022Late Stage Venture45.0M
2017Early Stage Venture6.0M
2016Seed

Investors

Theranica is funded by 24 investors.

Investor NameLead InvestorFunding RoundPartners
LionBird-FUNDING ROUND - LionBird6.0M
Theranica-FUNDING ROUND - Theranica6.0M
Theranica-FUNDING ROUND - Theranicaundefined
Shimon Eckhouse-FUNDING ROUND - Shimon Eckhouseundefined

Recent Activity

News

May 26, 2024

PR Newswire - DC Medicaid Becomes the First Medicaid Plan to Cover the Nerivio® REN Wearable, a Non-Drug Treatment for Migraine

News

Apr 17, 2024

Times of India - Dr Reddy’s rolls out drug-free migraine mgmt device in Europe

News

Apr 17, 2024

The Hindu - Dr. Reddy’s unveils Israeli firm Theranica’s migraine management wearable in Germany

News

Apr 10, 2024

The Hindu - Dr. Reddy’s unveils Israeli firm Theranica’s migraine management wearable in Germany

News

Apr 10, 2024

Business Standard - Dr Reddys launches migraine management wearable device Nerivio in Germany

News

Mar 05, 2024

PR Newswire - Theranica's REN Wearable Becomes the First Ever Non-Pharmacological Migraine Treatment to Receive Commercial ...